NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.130
-0.150 (-6.58%)
At close: Nov 19, 2025, 4:00 PM EST
2.200
+0.070 (3.29%)
After-hours: Nov 19, 2025, 7:08 PM EST
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $50.63 million as of November 19, 2025. Its market cap has increased by 242.19% in one year.
Market Cap
50.63M
Enterprise Value
57.27M
1-Year Change
242.19%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since December 4, 2017, NRx Pharmaceuticals's market cap has decreased from $82.80M to $50.63M, a decrease of -38.85%. That is a compound annual growth rate of -5.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 54.20M | 104.25% |
| Dec 31, 2024 | 26.53M | -30.71% |
| Dec 29, 2023 | 38.30M | -48.99% |
| Dec 30, 2022 | 75.08M | -73.29% |
| Dec 31, 2021 | 281.11M | 328.57% |
| Dec 31, 2020 | 65.59M | 1.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |